199 related articles for article (PubMed ID: 31432151)
41. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
[TBL] [Abstract][Full Text] [Related]
42. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
43. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
44. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
[TBL] [Abstract][Full Text] [Related]
45. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
PLoS One; 2017; 12(10):e0185636. PubMed ID: 28968424
[TBL] [Abstract][Full Text] [Related]
46. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.
Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ
Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226
[TBL] [Abstract][Full Text] [Related]
47. Hmga2 is required for neural crest cell specification in Xenopus laevis.
Macrì S; Simula L; Pellarin I; Pegoraro S; Onorati M; Sgarra R; Manfioletti G; Vignali R
Dev Biol; 2016 Mar; 411(1):25-37. PubMed ID: 26806704
[TBL] [Abstract][Full Text] [Related]
48. The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition.
Tan EJ; Kahata K; Idås O; Thuault S; Heldin CH; Moustakas A
Nucleic Acids Res; 2015 Jan; 43(1):162-78. PubMed ID: 25492890
[TBL] [Abstract][Full Text] [Related]
49. Germ line mutations of the HMGA2 gene are rare among the general population.
von Ahsen I; Rogalla P; Bullerdiek J
Anticancer Res; 2006; 26(5A):3289-91. PubMed ID: 17094442
[TBL] [Abstract][Full Text] [Related]
50. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2.
Zhang P; Bai H; Liu G; Wang H; Chen F; Zhang B; Zeng P; Wu C; Peng C; Huang C; Song Y; Song E
Toxicol Lett; 2015 May; 234(3):151-61. PubMed ID: 25725129
[TBL] [Abstract][Full Text] [Related]
52. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
[TBL] [Abstract][Full Text] [Related]
53. Hmga2 promoter analysis in transgenic mice.
Schiltz JF; Rustighi A; Tessari MA; Liu J; Braghetta P; Sgarra R; Stebel M; Bressan GM; Altruda F; Giancotti V; Chada K; Manfioletti G
Biochem Biophys Res Commun; 2003 Oct; 309(4):718-23. PubMed ID: 13679031
[TBL] [Abstract][Full Text] [Related]
54. High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation.
Boo LM; Lin HH; Chung V; Zhou B; Louie SG; O'Reilly MA; Yen Y; Ann DK
Cancer Res; 2005 Aug; 65(15):6622-30. PubMed ID: 16061642
[TBL] [Abstract][Full Text] [Related]
55. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
56. HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.
Dong J; Wang R; Ren G; Li X; Wang J; Sun Y; Liang J; Nie Y; Wu K; Feng B; Shang Y; Fan D
Clin Cancer Res; 2017 Jul; 23(13):3461-3473. PubMed ID: 28119367
[No Abstract] [Full Text] [Related]
57. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
Chen Z; Li Q; Wang S; Zhang J
Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
[TBL] [Abstract][Full Text] [Related]
58. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
[TBL] [Abstract][Full Text] [Related]
59. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis.
Thi-Hai Pham Y; Utuama O; Thomas CE; Park JA; La Vecchia C; Risch HA; Tran CT; Le TV; Boffetta P; Raskin L; Luu HN
Eur J Cancer Prev; 2020 Nov; 29(6):565-581. PubMed ID: 32898013
[TBL] [Abstract][Full Text] [Related]
60. Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia.
Tan L; Xu H; Chen G; Wei X; Yu B; Ye J; Xu L; Tan H
Br J Cancer; 2018 Feb; 118(3):405-415. PubMed ID: 29384529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
